These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 1116360

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood.
    Thijssen JH.
    Ann N Y Acad Sci; 1988; 538():280-6. PubMed ID: 3056190
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H, Pulkkinen MO, Hämäläinen EK, Korpela JT.
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids and sex hormone-binding globulin.
    Tafurt CA, Sobrevilla LA, de Estrada R.
    Fertil Steril; 1980 Mar; 33(3):261-6. PubMed ID: 6767626
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 10. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH, Poulsen HK, Teisner B, Thorsen P, Hau J, Westergaard JG.
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep 01; 51(1):63-71. PubMed ID: 7506680
    [Abstract] [Full Text] [Related]

  • 11. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A, Dewailly SD, Grenier R, Huard J.
    J Clin Endocrinol Metab; 1990 Jul 01; 71(1):8-14. PubMed ID: 2142494
    [Abstract] [Full Text] [Related]

  • 12. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol.
    Kharma K, Stone S, Thorneycroft IH, Nakamura RM, Mishell DR.
    Am J Obstet Gynecol; 1972 Mar 01; 112(5):676-80. PubMed ID: 4110418
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Disturbance of tryptophan metabolism and its correction during hormonal contraception.
    Bennink HJ, Schreurs WH.
    Contraception; 1974 Apr 01; 9(4):347-56. PubMed ID: 4442280
    [Abstract] [Full Text] [Related]

  • 15. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL, Langley MS, Robinson PA, Nummi S, Lund L.
    Fertil Steril; 1984 Jul 01; 42(1):44-51. PubMed ID: 6233179
    [Abstract] [Full Text] [Related]

  • 16. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K, Younis MN, Razek SA, Mekkawi TE, Nour H.
    Egypt Popul Fam Plann Rev; 1972 Jun 01; 5(1):145-51. PubMed ID: 12256025
    [Abstract] [Full Text] [Related]

  • 17. Distribution and percentages of non-protein bound contraceptive steroids in human serum.
    Hammond GL, Lähteenmäki PL, Lähteenmäki P, Luukkainen T.
    J Steroid Biochem; 1982 Oct 01; 17(4):375-80. PubMed ID: 6215538
    [Abstract] [Full Text] [Related]

  • 18. A visual aid to the classification of oral contraceptives.
    Law B, Mumford JP, Hoonakker EW.
    Curr Med Res Opin; 1974 Oct 01; 2(1):7-12. PubMed ID: 4135338
    [Abstract] [Full Text] [Related]

  • 19. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M, Kitchens CS, Khan FY.
    Am J Obstet Gynecol; 1992 Nov 01; 167(5):1255-61. PubMed ID: 1442974
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.